Lartruvo

Medicinal product

(Invented) name

Lartruvo

Active substance (s)

Olaratumabas

Strength

10 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX10, Olaratumab

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2016-11-09

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Olaratumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
67065	81608	1081608	flakonas	50 ml N1		Receptinis	EU/1/16/1143/001	Netiekiama	-	-	No	-	-
98257	84355	1084355	flakonas	19 ml N1		Receptinis	EU/1/16/1143/002	Netiekiama	-	-	No	-	-
98258	84356	1084356	flakonas	19 ml N2		Receptinis	EU/1/16/1143/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Išregistruotas
2016-11-09	Registruotas